Dry powder inhaler

Sovrin supply the Relenza dry powder inhaler (DPI) to one of the leading pharmaceutical companies. Their main criteria was to scale up high volume validated production in the shortest possible time. This meant that a bespoke production cell needed to be designed and built from scratch. High quality was engineered in, right from the beginning. The device is also sold to the Japanese market.
Sovrin solution

  • Production cell designed in-house at Sovrin
  • Sovrin capital expenditure investment fast tracked
  • New ISO 14644 Class 7 cleanroom constructed
  • In-line moulding and assembly
  • Annual capacity 6.5m devices
  • Cycle times optimised and harmonised
  • 5 new Fanuc injection moulding machines
  • Multi impression tooling
  • Compact 6 axis robot take out – 4 new robots
  • Anti static cooling conveyors
  • Gravimetric blending
  • Automated assembly and palletising
  • Bespoke packaging
  • Working in collaboration with client’s triple source strategy
  • Production ready in 6 months
  • Sovrin were the first supplier to market, by a considerable margin
  • 24/7 production
Start Typing